InMed Pharmaceuticals Inc. (INM) Institutional Ownership

Ownership Summary

InMed Pharmaceuticals Inc. (NASDAQ:INM) appears in 7 institutional 13F filings for the quarter ending December 2025.

• Their combined ownership stood at 5.7% of outstanding shares in December 2025, down from 7.7% in September 2025.
• They increased total shares held in InMed Pharmaceuticals by 3.06% from last quarter, and the number of investors in INM increased 16.67% annually.
• Activity in INM broke down as 3 buyers, 1 sellers, and 3 unchanged among 7 total holders.
• The aggregate institutional position in InMed Pharmaceuticals amounted to 227.05K shares as of December 2025, up by 6.74K shares quarter on quarter, and up 178.15K shares year over year.
• Private Wealth Management Group, LLC leads ownership in INM with 5.0K shares as of December 31, 2025, equal to 0.13% of outstanding shares.
• Leading buyers of InMed Pharmaceuticals shares for the quarter ending December 2025 were Private Wealth Management Group, LLC (5.0K).
• Business Quant data shows the 2 biggest positions in InMed Pharmaceuticals as of December 2025 are held by Private Wealth Management Group, LLC (5.0K), Banque Cantonale Vaudoise (6).